Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1824 (LINC01824)

Target
LINC01824
Molecular classification
Other (Long non-coding RNA, lncRNA; specifically, long intergenic non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 1824 (LINC01824) is a member of the long non-coding RNA (lncRNA) class, specifically falling under long intergenic non-coding RNAs (lincRNAs), which are defined as RNA transcripts longer than 200 nucleotides and located between protein-coding genes on the genome[1][5]. LINC01824 does not encode a protein; rather, like other lincRNAs, it is presumed to regulate gene expression at the epigenetic, transcriptional, and post-transcriptional level, although little is published about its specific function, biological role, or clinical relevance[1][5]. As of now, there is no direct evidence identifying LINC01824 as a therapeutic target, biomarker, or as having a well-characterized function or disease association[1][5]. Its aliases include LINC01824, ENSG00000226488 (Ensembl), and 107985844 (NCBI Gene)[1][5]. If you require information on the general mechanistic roles of lincRNAs, they can participate in chromatin remodeling, transcriptional regulation, and modulating mRNA stability, but such functions for LINC01824 specifically have not yet been demonstrated[6].

Other names
LINC01824ENSG00000226488 (Ensembl)107985844 (NCBI Gene)
02

Biological functions

Gene expression regulation (potential or inferred)Chromatin modification (general for lincRNAs, direct evidence for LINC01824 is lacking)
03

Disease associations

Other (no direct association with specific diseases or therapeutic roles established for LINC01824 as of current knowledge)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1824 (LINC01824).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1824 (LINC01824).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call